ArticleBMJ open2022

Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study.

Noa Eliakim-Raz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.